Phapros (PEHA) Overhauls Board of Directors and Commissioners, Here is the New Composition
JAKARTA, KOMPAS.com - The pharmaceutical issuer PT Phapros Tbk (PEHA) has overhauled its Board of Commissioners and Board of Directors through an Extraordinary General Meeting of Shareholders (EGMS), on Monday (27/3/2026).
Shareholders honourably dismissed Maxi Rein Rondonuwu as Chairman of the Board and Chrisma Aryani Albandjar as Independent Commissioner.
In the Board of Directors, the EGMS approved the removal of Yudhi Rangkuti from the position of Director of Finance, Risk Management & HR.
For the Board of Directors, the EGMS appointed Intan Abdams Katoppo as President Director.
Previously, this position was held by Ida Rahmi, who also served as Director of Production.
Then, Ferdinand Troedu as Director of Finance, Risk Management & HR.
According to him, the changes to the company’s Board of Commissioners and Board of Directors represent an organisational refreshment, with hopes that the company can continue the business transformation that has been initiated to achieve sustainable performance growth in the coming years.
“Phapros remains committed to providing the best health products and services to the Indonesian people and, at the same time, has a target to grow positively as a professional and healthy corporation. Because maintaining the trust of all stakeholders is our primary goal,” said Zahmilia, in a press statement on Wednesday (29/4/2026).
Here is the composition of Phapros’ Board of Directors and Commissioners according to the 2026 EGMS Decision.
Source: jawawa.id (https://jawawa.id/newsitem/phapros-peha-overhauls-board-of-directors-and-commissioners-here-is-the-new-composition-1777477917)
Originally published by Kompas (https://money.kompas.com/read/2026/04/29/215719826/phapros-peha-rombak-dewan-direksi-dan-komisaris-berikut-susunan-terbarunya?utm_source=ABC&utm_medium=rss), translated from Indonesian